NO20032731D0 - Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner - Google Patents

Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner

Info

Publication number: NO20032731D0
Authority: NO; Norway
Prior art keywords: sulfonamide; preparation; substituted imidazotriazinones; imidazotriazinones; substituted
Prior art date: 2000-12-18

Application number

NO20032731A

Other languages

English (en)

Other versions

NO325398B1 (no

NO20032731L (no

Inventor

Marc Nowakowski

Reinhold Gehring

Werner Heilmann

Karl-Heinz Wahl

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-18

Filing date

2003-06-16

Publication date

2003-06-16

2003-06-16 Application filed by Bayer Ag filed Critical Bayer Ag

2003-06-16 Publication of NO20032731L publication Critical patent/NO20032731L/no

2003-06-16 Publication of NO20032731D0 publication Critical patent/NO20032731D0/no

2008-04-21 Publication of NO325398B1 publication Critical patent/NO325398B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Endocrinology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Reproductive Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Cosmetics (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20032731A 2000-12-18 2003-06-16 Fremgangsmate for fremstilling av sulfonamid-substituerte imidazotriazinoner NO325398B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10063108A DE10063108A1 (de)	2000-12-18	2000-12-18	Verfahren zur Herstellung von Sulfonamid-substituierten Imidazotriazinonen
PCT/EP2001/014239 WO2002050076A2 (de)	2000-12-18	2001-12-05	Verfahren zur herstellung von sulfonamid-substituierten imidazotriazinonen

Publications (3)

Publication Number	Publication Date
NO20032731L NO20032731L (no)	2003-06-16
NO20032731D0 true NO20032731D0 (no)	2003-06-16
NO325398B1 NO325398B1 (no)	2008-04-21

Family

ID=7667666

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20032731A NO325398B1 (no)	2000-12-18	2003-06-16	Fremgangsmate for fremstilling av sulfonamid-substituerte imidazotriazinoner

Country Status (42)

Country	Link
US (3)	US6777551B2 (no)
EP (1)	EP1345939B1 (no)
JP (1)	JP4441175B2 (no)
KR (1)	KR100787288B1 (no)
CN (1)	CN1227253C (no)
AR (1)	AR032775A1 (no)
AT (1)	ATE328885T1 (no)
AU (2)	AU1708902A (no)
BG (1)	BG66142B1 (no)
BR (1)	BRPI0116227B8 (no)
CA (1)	CA2431933C (no)
CU (2)	CU23341B7 (no)
CY (1)	CY1105197T1 (no)
CZ (1)	CZ297005B6 (no)
DE (2)	DE10063108A1 (no)
DK (1)	DK1345939T3 (no)
DO (1)	DOP2001000295A (no)
EC (1)	ECSP034657A (no)
EE (1)	EE05308B1 (no)
ES (1)	ES2266098T3 (no)
GT (1)	GT200100251A (no)
HN (1)	HN2001000278A (no)
HR (1)	HRP20030583B1 (no)
HU (1)	HU229296B1 (no)
IL (2)	IL156278A0 (no)
MA (1)	MA25927A1 (no)
MX (1)	MXPA03005429A (no)
MY (1)	MY126689A (no)
NO (1)	NO325398B1 (no)
NZ (1)	NZ526477A (no)
PE (1)	PE20020590A1 (no)
PL (1)	PL207294B1 (no)
PT (1)	PT1345939E (no)
RU (1)	RU2299211C2 (no)
SI (1)	SI1345939T1 (no)
SK (1)	SK286894B6 (no)
SV (1)	SV2003000766A (no)
TW (1)	TWI289562B (no)
UA (1)	UA75109C2 (no)
UY (2)	UY27070A1 (no)
WO (1)	WO2002050076A2 (no)
ZA (1)	ZA200304705B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10063108A1 (de) *	2000-12-18	2002-06-20	Bayer Ag	Verfahren zur Herstellung von Sulfonamid-substituierten Imidazotriazinonen
DE10107639A1 (de) *	2001-02-15	2002-08-22	Bayer Ag	2-Alkoxyphenyl-substituierte Imidazotriazinone
DE10232113A1 (de)	2002-07-16	2004-01-29	Bayer Ag	Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
DE202004006552U1 (de) *	2004-04-26	2004-07-08	Knürr AG	Kühlungssystem für Geräte- und Netzwerkschränke
DE102004023069A1 (de)	2004-05-11	2005-12-08	Bayer Healthcare Ag	Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
US7977478B2 (en) *	2006-03-13	2011-07-12	Dr. Reddy's Laboratories Limited	Polymorphic forms of vardenafil
WO2009030095A1 (fr) *	2007-09-06	2009-03-12	Topharman Shanghai Co., Ltd.	Procédé de préparation de vardénafil et de ses intermédiaires
WO2009082845A1 (fr)	2007-12-28	2009-07-09	Topharman Shanghai Co., Ltd.	N-{1-[3-(2-éthoxy-5-(4-éthylpipérazinyl)benzènesulfonyl)-4,5-dihydro-5-oxo-1,2,4-triazin-6-yl]éthyl}butyramide, son procédé de préparation et son utilisation
CA2770471A1 (en)	2009-08-07	2011-02-10	Ranbaxy Laboratories Limited	Processes for the preparation of vardenafil
PL390079A1 (pl) *	2009-12-30	2011-07-04	Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna	Sposób otrzymywania wardenafilu i jego izolacji jako soli z kwasem cytrynowym oraz krystaliczna postać tej soli
CN102134242B (zh)	2011-01-21	2013-08-28	浙江大德药业集团有限公司	一种用于治疗阳痿的快速长效的化合物
CZ2011767A3 (cs)	2011-11-24	2013-06-05	Zentiva, K.S.	Zpusob prípravy a izolace solí vardenafilu s kyselinami
US20160317542A1 (en)	2013-12-09	2016-11-03	Respira Therapeutics, Inc.	Pde5 inhibitor powder formulations and methods relating thereto
PL223869B1 (pl)	2013-12-16	2016-11-30	Starogardzkie Zakłady Farm Polpharma Spółka Akcyjna	Sposób otrzymywania wardenafilu i jego soli
CN107383020A (zh) *	2017-07-29	2017-11-24	合肥创新医药技术有限公司	一种伐地那非杂质的制备方法
CA3085219A1 (en)	2017-12-20	2019-06-27	Klaria Pharma Holding Ab	Film formulation comprising vardenafil, method for its preparation, and use thereof
CN115043757B (zh) *	2022-07-27	2023-08-08	南京桦冠生物技术有限公司	一种连续化制备苄脒盐酸盐的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9311920D0 (en) *	1993-06-09	1993-07-28	Pfizer Ltd	Therapeutic agents
IL135462A0 (en)	1997-11-12	2001-05-20	Bayer Ag	2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
DE10063108A1 (de) *	2000-12-18	2002-06-20	Bayer Ag	Verfahren zur Herstellung von Sulfonamid-substituierten Imidazotriazinonen
DE10107639A1 (de) *	2001-02-15	2002-08-22	Bayer Ag	2-Alkoxyphenyl-substituierte Imidazotriazinone

2000
- 2000-12-18 DE DE10063108A patent/DE10063108A1/de not_active Withdrawn
2001
- 2001-05-12 UA UA2003076744A patent/UA75109C2/uk unknown
- 2001-11-28 AR ARP010105546A patent/AR032775A1/es active IP Right Grant
- 2001-11-28 DO DO2001000295A patent/DOP2001000295A/es unknown
- 2001-12-05 BR BRPI0116227A patent/BRPI0116227B8/pt not_active IP Right Cessation
- 2001-12-05 AU AU1708902A patent/AU1708902A/xx active Pending
- 2001-12-05 EP EP01271374A patent/EP1345939B1/de not_active Expired - Lifetime
- 2001-12-05 CZ CZ20031692A patent/CZ297005B6/cs not_active IP Right Cessation
- 2001-12-05 KR KR1020037008063A patent/KR100787288B1/ko not_active Expired - Lifetime
- 2001-12-05 NZ NZ526477A patent/NZ526477A/xx not_active IP Right Cessation
- 2001-12-05 JP JP2002551969A patent/JP4441175B2/ja not_active Expired - Lifetime
- 2001-12-05 PT PT01271374T patent/PT1345939E/pt unknown
- 2001-12-05 ES ES01271374T patent/ES2266098T3/es not_active Expired - Lifetime
- 2001-12-05 HR HR20030583A patent/HRP20030583B1/xx not_active IP Right Cessation
- 2001-12-05 DK DK01271374T patent/DK1345939T3/da active
- 2001-12-05 WO PCT/EP2001/014239 patent/WO2002050076A2/de not_active Ceased
- 2001-12-05 RU RU2003122192/04A patent/RU2299211C2/ru active
- 2001-12-05 MX MXPA03005429A patent/MXPA03005429A/es active IP Right Grant
- 2001-12-05 AU AU2002217089A patent/AU2002217089B2/en not_active Expired
- 2001-12-05 AT AT01271374T patent/ATE328885T1/de active
- 2001-12-05 CA CA002431933A patent/CA2431933C/en not_active Expired - Lifetime
- 2001-12-05 EE EEP200300294A patent/EE05308B1/xx unknown
- 2001-12-05 SI SI200130606T patent/SI1345939T1/sl unknown
- 2001-12-05 HU HU0302467A patent/HU229296B1/hu unknown
- 2001-12-05 CN CNB018208177A patent/CN1227253C/zh not_active Expired - Lifetime
- 2001-12-05 DE DE50110080T patent/DE50110080D1/de not_active Expired - Lifetime
- 2001-12-05 PL PL365310A patent/PL207294B1/pl unknown
- 2001-12-05 SK SK750-2003A patent/SK286894B6/sk not_active IP Right Cessation
- 2001-12-13 MY MYPI20015689A patent/MY126689A/en unknown
- 2001-12-14 GT GT200100251A patent/GT200100251A/es unknown
- 2001-12-14 UY UY27070A patent/UY27070A1/es not_active IP Right Cessation
- 2001-12-14 HN HN2001000278A patent/HN2001000278A/es unknown
- 2001-12-15 IL IL15627801A patent/IL156278A0/xx unknown
- 2001-12-17 PE PE2001001258A patent/PE20020590A1/es active IP Right Grant
- 2001-12-17 TW TW090131175A patent/TWI289562B/zh not_active IP Right Cessation
- 2001-12-17 US US10/022,954 patent/US6777551B2/en not_active Expired - Lifetime
- 2001-12-17 SV SV2001000766A patent/SV2003000766A/es active IP Right Grant
2003
- 2003-06-03 IL IL156278A patent/IL156278A/en active IP Right Grant
- 2003-06-09 BG BG107892A patent/BG66142B1/bg unknown
- 2003-06-09 CU CU20030128A patent/CU23341B7/es unknown
- 2003-06-16 NO NO20032731A patent/NO325398B1/no not_active IP Right Cessation
- 2003-06-17 EC EC2003004657A patent/ECSP034657A/es unknown
- 2003-06-18 ZA ZA200304705A patent/ZA200304705B/en unknown
- 2003-06-18 MA MA27202A patent/MA25927A1/fr unknown
2004
- 2004-07-02 US US10/884,686 patent/US20050014756A1/en not_active Abandoned
2005
- 2005-05-05 US US11/124,452 patent/US6998483B2/en not_active Expired - Lifetime
2006
- 2006-09-05 CY CY20061101263T patent/CY1105197T1/el unknown
2008
- 2008-11-17 CU CUP2008000213A patent/CU23873B1/es active IP Right Grant
2017
- 2017-03-28 UY UY0001037172A patent/UY37172A/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
ECSP034657A (es)	2003-07-25
MY126689A (en)	2006-10-31
BRPI0116227B8 (pt)	2021-05-25
HK1063799A1 (en)	2005-01-14
BR0116227B1 (pt)	2014-08-26
HRP20030583A2 (en)	2005-06-30
EP1345939B1 (de)	2006-06-07
HN2001000278A (es)	2002-01-30
EP1345939A2 (de)	2003-09-24
WO2002050076A2 (de)	2002-06-27
PT1345939E (pt)	2006-08-31
BR0116227A (pt)	2003-12-30
HRP20030583B1 (hr)	2011-09-30
KR20030063430A (ko)	2003-07-28
JP2004517849A (ja)	2004-06-17
UA75109C2 (en)	2006-03-15
PE20020590A1 (es)	2002-07-13
ATE328885T1 (de)	2006-06-15
CY1105197T1 (el)	2010-03-03
HUP0302467A2 (hu)	2003-11-28
UY27070A1 (es)	2002-07-31
CZ297005B6 (cs)	2006-08-16
CN1227253C (zh)	2005-11-16
RU2299211C2 (ru)	2007-05-20
BG107892A (bg)	2004-08-31
HU229296B1 (en)	2013-10-28
CU23873B1 (es)	2013-04-19
KR100787288B1 (ko)	2007-12-20
DOP2001000295A (es)	2002-12-15
AR032775A1 (es)	2003-11-26
EE200300294A (et)	2003-10-15
DE10063108A1 (de)	2002-06-20
PL365310A1 (en)	2004-12-27
NO325398B1 (no)	2008-04-21
US20050014756A1 (en)	2005-01-20
US20020137930A1 (en)	2002-09-26
HUP0302467A3 (en)	2004-11-29
WO2002050076A3 (de)	2002-08-29
CU23341B7 (es)	2009-02-20
ES2266098T3 (es)	2007-03-01
IL156278A0 (en)	2004-01-04
DE50110080D1 (de)	2006-07-20
SI1345939T1 (sl)	2006-10-31
NZ526477A (en)	2004-12-24
BG66142B1 (bg)	2011-07-29
DK1345939T3 (da)	2006-09-25
IL156278A (en)	2009-06-15
NO20032731L (no)	2003-06-16
MA25927A1 (fr)	2003-10-01
CN1481386A (zh)	2004-03-10
UY37172A (es)	2017-06-30
AU2002217089B2 (en)	2006-01-12
US6998483B2 (en)	2006-02-14
SK286894B6 (sk)	2009-07-06
CA2431933A1 (en)	2002-06-27
TWI289562B (en)	2007-11-11
SV2003000766A (es)	2003-01-13
SK7502003A3 (en)	2003-10-07
US20050203298A1 (en)	2005-09-15
AU1708902A (en)	2002-07-01
US6777551B2 (en)	2004-08-17
CA2431933C (en)	2009-12-01
CZ20031692A3 (cs)	2003-10-15
PL207294B1 (pl)	2010-11-30
ZA200304705B (en)	2004-08-12
CU20080213A7 (es)	2012-06-21
EE05308B1 (et)	2010-06-15
GT200100251A (es)	2002-10-01
JP4441175B2 (ja)	2010-03-31
MXPA03005429A (es)	2004-05-04

Publication	Publication Date	Title
NO20030012L (no)	2003-03-03	Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20042680L (no)	2004-06-25	Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20013943L (no)	2002-02-19	Fremgangsmate for fremstilling av Citalopram
FI20011578A0 (fi)	2001-07-26	Menetelmä puhtaan sitalopraamin valmistamiseksi
NO20011271A (no)	2002-05-13	Fremgangsmåte for fremstilling av ren citalopram
NO20023928L (no)	2002-08-19	Fremgangsmåte ved fremstillingen av citalopram
NO20030163L (no)	2003-02-27	Fremgangsmate for fremstilling av olefiner
NO20024007D0 (no)	2002-08-22	Fremgangsmåte ved fremstillingen av citalopram
NO20040027L (no)	2004-01-05	Fremgangsmate for fremstillingen av escitalopram
NO20032731D0 (no)	2003-06-16	Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner
NO20040278L (no)	2004-01-21	Fremgangsmate for fremstilling av perindopril
NO20035538D0 (no)	2003-12-11	Fremgangsmåte for fremstilling av zaleplon
NO20042640L (no)	2004-06-23	Fremgangsmate for fremstilling av ekinocandinderivater
NO20025423L (no)	2002-11-12	Fremgangsmate for fremstilling av Citalopram
NO20024180D0 (no)	2002-09-02	Fremgangsmåte ved fremstillingen av citalopram
NO20023445D0 (no)	2002-07-18	Fremgangsmåte for fremstilling av peptider
NO20030515L (no)	2003-03-31	Fremgangsmåte for fremstilling av dinapsolin
NO20024213D0 (no)	2002-09-04	Fremgangsmåte ved fremstilling av citalopram
NO20026155D0 (no)	2002-12-20	Fremgangsmåte for fremstilling av lavere olefiner
NO20021118D0 (no)	2002-03-06	Fremgangsmåte for fremstilling av citalopram
NO20024214D0 (no)	2002-09-04	Fremgangsmåte ved fremstilling av citalopram
NO20024887D0 (no)	2002-10-10	Fremgangsmåte for fremstilling av benzokondenserte heterosykliske forbindelser
NO20023702D0 (no)	2002-08-06	Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20032297L (no)	2003-05-21	Fremgangsmåte for fremstilling av distamycinderivater
NO20020328D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol

Legal Events

Date	Code	Title	Description
2013-06-17	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE
2021-12-13	MK1K	Patent expired